VERU VERU INC.

$2.95 -1.83%

Healthcare · Pharmaceutical Preparations

VERU INC. (VERU) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $47 million. Shares last traded at $2.95, 59.5% below their 52-week high. Over the past year the stock is up 407.7%. Net profit margin is -134.6%, below the peer median of -0.1%. Revenue grew 3.6% year over year. The shares yield 19.0% in dividends.

Market Cap

$47M

Shares Out

16.1M

EPS (TTM)

$-1.96

P/E Ratio

—

P/S Ratio

2.80

P/B Ratio

1.36

Dividend / Share

$0.56

Dividend Yield

18.98%

52-Week High

$7.29

52-Week Low

$0.36

Volume

12,552

Avg Vol (3m)

47,128.079

Performance

-10.06%

+41.15%

+27.71%

+22.92%

YTD

+28.26%

+407.66%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

54.93

SMA (50)

$2.48

SMA (200)

$2.73

Price vs SMA50

+18.87%

Price vs SMA200

+8.21%

ATR (14)

$0.40

Financials

Revenue

$17M

Net Income

$-23M

Gross Margin

34.7%

Operating Margin

-146.6%

Net Margin

-134.6%

Return on Equity

-65.3%

Return on Assets

-52.8%

Current Ratio

6.19

Debt / Equity

0.05

Revenue Growth (YoY)

+3.6%

Latest reported annual period ending 2024-09-30 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q2 2024	$-0.15	2024-05-08
Q1 2024	$-0.08	2024-04-01
FY 2023	$-1.10	2023-12-08
Q3 2023	$-0.83	2023-08-10
Q2 2024	$-0.90	2024-05-08
Q1 2024	$-0.48	2024-04-01

Full earnings history →

Pharmaceutical Preparations peers

VERU vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

2.80 / 3.54 med

-21% discount

Net margin vs peers

-134.6% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.